NEW MEDICINAL APPLICATION OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR (ACEI) IN TREATING DYSPEPTIC SYMPTOMS Russian patent published in 2003 - IPC

Abstract RU 2203092 C2

FIELD: medicine. SUBSTANCE: method deals with application of new pharmaceutical composition and corresponding method of therapy. New preparation (enalapril, in particular) causes pronounced palliative action upon symptoms and decreases usage of antacid remedies. The present innovation increases the number of preparations of mentioned indication. EFFECT: higher efficiency of application. 5 cl

Similar patents RU2203092C2

Title Year Author Number
PHARMACEUTICAL PREPARATIONS AND THEIR USING FOR PROPHYLAXIS OF STROKE, DIABETES AND/OR CONGESTIVE CARDIAC INSUFFICIENCY 2000
  • Shelkens Bernvard
  • Bender Norbert
  • Rangoonvala Badrudin
  • Dazhene Zhill'
  • Gershtajn Kherttsel'
  • Junggren Anders
  • Jusuf Salim
RU2272651C2
PHARMACEUTICAL PREPARATIONS AND THEIR APPLICATION FOR PREVENTION OF STROKE, DIABETES AND/OR CONGESTIVE HEART FAILURE 2005
  • Shelkens Bernvard
  • Bender Norbert
  • Rangoonvala Badrudin
  • Dazhene Zhill'
  • Gershtajn Kherttsel'
  • Junggren Anders
  • Jusuf Salim
RU2378018C2
APPLICATION OF ANGIOTENSIN II RECEPTOR ANTAGONISTS FOR TREATMENT OF ACUTE MYOCARDIAL INFARCTION 2006
  • Mann Essika M.
  • Oddu Paskal'
  • Nehar Ehrik Mishel'
RU2345790C2
PHARMACEUTICAL COMPOSITION 1997
  • Tsudzita Josio
  • Fudzivara Tosikhiko
  • Sada Tosio
  • Maeda Naojuki
RU2183128C2
DERIVATIVES OF SUBSTITUTED PHENYLPROPIONIC ACID AS AGONISTS OF HUMAN ALPHA-RECEPTORS ACTIVATED BY PEROXISOME PROLIFERATOR (PPARα), METHOD AND INTERMEDIATE COMPOUNDS FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, THEIR USING AND METHODS FOR TREATMENT OF DYSLIPIDEMIA IN DIABETES MELLITUS TYPE 2 2002
  • Al'Stermark Lindstedt Ehva-Lotte
  • Ol'Sson Anna Kristina
  • Li Lanna
RU2303031C2
COMBINATION OF AT LEAST TWO COMPOUNDS CHOSEN FROM GROUPS AT-RECEPTOR ANTAGONISTS OR INHIBITORS OF ACE (ANGIOTENSIN-CONVERTING ENZYME) OR INHIBITORS OF HMG-COA-REDUCTASE (BETA-HYDROXY-BETA-METHYLGLUTARYL-COENZYME-A-REDUCTASE) 2001
  • De-Gasparo Mark
  • Grejvz Kurt S.
RU2298418C2
DERIVATIVES OF SUBSTITUTED PHENYLPROPIONIC ACID AS AGONISTS OF HUMAN ALPHA-RECEPTOR (PPARα) ACTIVATED BY PEROXISOME PROLIFERATORS, METHOD AND INTERMEDIATE COMPOUNDS FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, THEIR USING AND METHODS FOR DYSLIPIDEMIA TREATMENT AND TYPE 2 DIABETES MELLITUS 2002
  • Al'Stermark Lindstedt Ehva-Lotte
  • Ol'Sson Anna Kristina
  • Li Lanna
RU2300517C2
LIQUID COMPOSITION 2013
  • Bova Nikolas
  • Pejdzh Stefen
  • Pippiya Dzhuzeppe
RU2640023C2
ANGIOTENSIN CONVERTING ENZYME INHIBITORS FOR TREATING OPTIC NEUROPATHY OR CONGENITAL OPTIC ATROPHY 2013
  • Rekik Rauf
RU2658461C2
PHARMACEUTICAL COMPOSITION COMPRISING ALDEHYDE REDUCTASE INHIBITOR AND ACE INHIBITOR 1998
  • Kehri Frehnk
  • Taffin Dehvid Patrik
  • Kehmeron Norman Judzhin
  • Kotter Mehri Ehnn
RU2216354C2

RU 2 203 092 C2

Authors

Fendriks Lars

Pettersson Anders

Dates

2003-04-27Published

1996-12-20Filed